Cargando…
Identification of the Novel Tumor Suppressor Role of FOCAD/miR-491-5p to Inhibit Cancer Stemness, Drug Resistance and Metastasis via Regulating RABIF/MMP Signaling in Triple Negative Breast Cancer
Triple negative breast cancer (TNBC) possesses poor prognosis mainly due to development of chemoresistance and lack of effective endocrine or targeted therapies. MiR-491-5p has been found to play a tumor suppressor role in many cancers including breast cancer. However, the precise role of miR-491-5p...
Autores principales: | Huang, Wei-Chieh, Chi, Hsiang-Cheng, Tung, Shiao-Lin, Chen, Po-Ming, Shih, Ya-Chi, Huang, Yi-Ching, Chu, Pei-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534268/ https://www.ncbi.nlm.nih.gov/pubmed/34685504 http://dx.doi.org/10.3390/cells10102524 |
Ejemplares similares
-
Germline deletions in the tumour suppressor gene FOCAD are associated with polyposis and colorectal cancer development
por: Weren, Robbert DA, et al.
Publicado: (2015) -
Discovery of FOCAD: An Important Gene in Liver Cirrhosis
por: Shao, Jinjin
Publicado: (2022) -
IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway
por: Huang, Wei-Chieh, et al.
Publicado: (2018) -
Novel function of THEMIS2 in the enhancement of cancer stemness and chemoresistance by releasing PTP1B from MET
por: Huang, Wei-Chieh, et al.
Publicado: (2022) -
SUN-491 A Diagnosis of Thyroid Cancer Reveals a Triple Threat
por: Dengler, Samuel Lee, et al.
Publicado: (2020)